{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:32:47Z","timestamp":1778081567827,"version":"3.51.4"},"publisher-location":"Singapore","reference-count":104,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811335877","type":"print"},{"value":"9789811335884","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-3588-4_15","type":"book-chapter","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T12:03:36Z","timestamp":1555070616000},"page":"281-298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Clinical Application of AMPs"],"prefix":"10.1007","author":[{"given":"Fab\u00edola","family":"Costa","sequence":"first","affiliation":[]},{"given":"C\u00e1tia","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"M. Cristina L.","family":"Martins","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,4,13]]},"reference":[{"issue":"6","key":"15_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2174\/138161212799277617","volume":"18","author":"NJ Afacan","year":"2012","unstructured":"Afacan NJ, Yeung AT, Pena OM, Hancock RE (2012) Therapeutic potential of host defense peptides in antibiotic-resistant infections. Curr Pharm Des 18(6):807\u2013819","journal-title":"Curr Pharm Des"},{"issue":"7","key":"15_CR2","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1016\/j.bmc.2008.01.019","volume":"16","author":"HS Ahn","year":"2008","unstructured":"Ahn HS, Cho W, Kim JM, Joshi BP, Park JW, Lohani CR, Cho H, Lee KH (2008) Design and synthesis of cyclic disulfide-bonded antibacterial peptides on the basis of the alpha helical domain of Tenecin 1, an insect defensin. Bioorg Med Chem 16(7):4127\u20134137","journal-title":"Bioorg Med Chem"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.2147\/DDDT.S147450","volume":"11","author":"A Almaaytah","year":"2017","unstructured":"Almaaytah A, Mohammed GK, Abualhaijaa A, Al-Balas Q (2017) Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria. Drug Des Dev Ther 11:3159\u20133170","journal-title":"Drug Des Dev Ther"},{"issue":"1\u20133","key":"15_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.colsurfa.2004.08.041","volume":"249","author":"N Alminana","year":"2004","unstructured":"Alminana N, Alsina MA, Ortiz A, Reig F (2004) Comparative physicochemical study of SIKVAV peptide and its retro and retro-enantio analogues. Colloids Surf A: Physicochem Eng Asp 249(1\u20133):19\u201324","journal-title":"Colloids Surf A: Physicochem Eng Asp"},{"issue":"2","key":"15_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom8020019","volume":"8","author":"M Arias","year":"2018","unstructured":"Arias M, Piga KB, Hyndman ME, Vogel HJ (2018) Improving the activity of Trp-rich antimicrobial peptides by Arg\/Lys substitutions and changing the length of cationic residues. Biomolecules 8(2):1\u201317","journal-title":"Biomolecules"},{"issue":"6","key":"15_CR6","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.drudis.2017.02.001","volume":"22","author":"NG Bednarska","year":"2017","unstructured":"Bednarska NG, Wren BW, Willcocks SJ (2017) The importance of the glycosylation of antimicrobial peptides: natural and synthetic approaches. Drug Discov Today 22(6):919\u2013926","journal-title":"Drug Discov Today"},{"issue":"4","key":"15_CR7","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1021\/bm101547d","volume":"12","author":"T Blin","year":"2011","unstructured":"Blin T, Purohit V, Leprince J, Jouenne T, Glinel K (2011) Bactericidal microparticles decorated by an antimicrobial peptide for the easy disinfection of sensitive aqueous solutions. Biomacromolecules 12(4):1259\u20131264","journal-title":"Biomacromolecules"},{"issue":"11","key":"15_CR8","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1128\/aem.62.11.4086-4094.1996","volume":"62","author":"DG Bourne","year":"1996","unstructured":"Bourne DG, Jones GJ, Blakeley RL, Jones A, Negri AP, Riddles P (1996) Enzymatic pathway for the bacterial degradation of the cyanobacterial cyclic peptide toxin microcystin LR. Appl Environ Microbiol 62(11):4086\u20134094","journal-title":"Appl Environ Microbiol"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.addr.2014.10.027","volume":"78","author":"BD Brooks","year":"2014","unstructured":"Brooks BD, Brooks AE (2014) Therapeutic strategies to combat antibiotic resistance. Adv Drug Deliv Rev 78:14\u201327","journal-title":"Adv Drug Deliv Rev"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/B978-0-08-100736-5.00005-3","volume-title":"Peptide applications in biomedicine, biotechnology and bioengineering","author":"MH Cardoso","year":"2018","unstructured":"Cardoso MH, C\u00e2ndido ES, Oshiro KGN, Rezende SB, Franco OL (2018) Peptides containing D-amino acids and retro-inverso peptides: general applications and special focus on antimicrobial peptides. In: Koutsopoulos S (ed) Peptide applications in biomedicine, biotechnology and bioengineering. Woodhead Publishing, Elsevier Ltd, Kidlington, pp 131\u2013155"},{"issue":"10","key":"15_CR11","doi-asserted-by":"publisher","first-page":"18040","DOI":"10.3390\/ijms151018040","volume":"15","author":"AM Carmona-Ribeiro","year":"2014","unstructured":"Carmona-Ribeiro AM, Carrasco LDD (2014) Novel formulations for antimicrobial peptides. Int J Mol Sci 15(10):18040\u201318083","journal-title":"Int J Mol Sci"},{"issue":"1","key":"15_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/anie.201205674","volume":"52","author":"J Chatterjee","year":"2013","unstructured":"Chatterjee J, Rechenmacher F, Kessler H (2013) N-methylation of peptides and proteins: an important element for modulating biological functions. Angew Chem Int Ed 52(1):254\u2013269","journal-title":"Angew Chem Int Ed"},{"issue":"12","key":"15_CR13","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.1021\/jo500699m","volume":"79","author":"O Cheneval","year":"2014","unstructured":"Cheneval O, Schroeder CI, Durek T, Walsh P, Huang YH, Liras S, Price DA, Craik DJ (2014) Fmoc-based synthesis of disulfide-rich cyclic peptides. J Org Chem 79(12):5538\u20135544","journal-title":"J Org Chem"},{"issue":"9","key":"15_CR14","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1128\/AAC.45.9.2441-2449.2001","volume":"45","author":"C Chicharro","year":"2001","unstructured":"Chicharro C, Granata C, Lozano R, Andreu D, Rivas L (2001) N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide. Antimicrob Agents Chemother 45(9):2441\u20132449","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"15_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1039\/C4MD00131A","volume":"6","author":"Q Chu","year":"2015","unstructured":"Chu Q, Moellering RE, Hilinski GJ, Kim YW, Grossmann TN, Yeh JTH, Verdine GL (2015) Towards understanding cell penetration by stapled peptides. Medchemcomm 6(1):111\u2013119","journal-title":"Medchemcomm"},{"key":"15_CR16","unstructured":"ClinicalTrials.gov (n.d.) https:\/\/www.clinicaltrials.gov\/"},{"key":"15_CR17","unstructured":"ClinicalTrialsPage (n.d.) https:\/\/www.nia.nih.gov\/health\/what-are-clinical-trials-and-studies. Accessed Jul 2018."},{"issue":"1","key":"15_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1476-5381.2011.01250.x","volume":"163","author":"ARM Coates","year":"2011","unstructured":"Coates ARM, Halls G, Hu YM (2011) Novel classes of antibiotics or more of the same? Br J Pharmacol 163(1):184\u2013194","journal-title":"Br J Pharmacol"},{"issue":"41","key":"15_CR19","doi-asserted-by":"publisher","first-page":"11561","DOI":"10.1073\/pnas.1608623113","volume":"113","author":"SA Cochrane","year":"2016","unstructured":"Cochrane SA, Findlay B, Bakhtiary A, Acedo JZ, Rodriguez-Lopez EM, Mercier P, Vederas JC (2016) Antimicrobial lipopeptide tridecaptin A(1) selectively binds to gram-negative lipid II. Proc Natl Acad Sci U S A 113(41):11561\u201311566","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR20","unstructured":"Collins JJ, Koeris M, Lu TKT, et al. (2015) Bacteriophages expressing antimicrobial peptides and uses thereof. US 2015\/0050717 A1"},{"issue":"4","key":"15_CR21","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.actbio.2010.11.005","volume":"7","author":"F Costa","year":"2011","unstructured":"Costa F, Carvalho IF, Montelaro RC, Gomes P, Martins MCL (2011) Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces. Acta Biomater 7(4):1431\u20131440","journal-title":"Acta Biomater"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biomaterials.2015.02.049","volume":"52","author":"FMTA Costa","year":"2015","unstructured":"Costa FMTA, Maia SR, Gomes PAC, Martins MCL (2015) Dhvar5 antimicrobial peptide (AMP) chemoselective covalent immobilization results on higher antiadherence effect than simple physical adsorption. Biomaterials 52:531\u2013538","journal-title":"Biomaterials"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.colsurfb.2015.08.027","volume":"135","author":"I d\u2019Angelo","year":"2015","unstructured":"d\u2019Angelo I, Casciaro B, Miro A, Quaglia F, Mangoni ML, Ungaro F (2015) Overcoming barriers in Pseudomonas aeruginosa lung infections: engineered nanoparticles for local delivery of a cationic antimicrobial peptide. Colloids Surf B:Biointerfaces 135:717\u2013725","journal-title":"Colloids Surf B:Biointerfaces"},{"issue":"8","key":"15_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/psc.491","volume":"9","author":"JS Davies","year":"2003","unstructured":"Davies JS (2003) The cyclization of peptides and depsipeptides. J Pept Sci 9(8):471\u2013501","journal-title":"J Pept Sci"},{"issue":"1","key":"15_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","volume":"17","author":"L Di","year":"2015","unstructured":"Di L (2015) Strategic approaches to optimizing peptide ADME properties. AAPS J 17(1):134\u2013143","journal-title":"AAPS J"},{"issue":"5","key":"15_CR26","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/psc.2755","volume":"21","author":"M Di Pisa","year":"2015","unstructured":"Di Pisa M, Chassaing G, Swiecicki JM (2015) When cationic cell-penetrating peptides meet hydrocarbons to enhance in-cell cargo delivery. J Pept Sci 21(5):356\u2013369","journal-title":"J Pept Sci"},{"issue":"9","key":"15_CR27","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","volume":"21","author":"BC Doak","year":"2014","unstructured":"Doak BC, Over B, Giordanetto F, Kihlberg J (2014) Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Chem Biol 21(9):1115\u20131142","journal-title":"Chem Biol"},{"issue":"5","key":"15_CR28","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1021\/bc050172r","volume":"16","author":"DH Doherty","year":"2005","unstructured":"Doherty DH, Rosendahl MS, Smith DJ, Hughes JM, Chlipala EA, Cox GN (2005) Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor. Bioconjug Chem 16(5):1291\u20131298","journal-title":"Bioconjug Chem"},{"issue":"3","key":"15_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/chem.200500557","volume":"12","author":"KJ Doores","year":"2006","unstructured":"Doores KJ, Gamblin DP, Davis BG (2006) Exploring and exploiting the therapeutic potential of glycoconjugates. Chem Eur J 12(3):656\u2013665","journal-title":"Chem Eur J"},{"key":"15_CR30","unstructured":"DrugDataBase (n.d.) http:\/\/www.drugsdb.eu\/index.php?l=c. Accessed Jul 2018."},{"key":"15_CR31","unstructured":"Eckert RH, Yarbrough D, Shi W, et al (2014) Selectively targeted antimicrobial peptides and the use thereof. EP2801368A1 2014"},{"issue":"5","key":"15_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms17050785","volume":"17","author":"A Falanga","year":"2016","unstructured":"Falanga A, Lombardi L, Franci G, Vitiello M, Iovene MR, Morelli G, Galdiero M, Galdiero S (2016) Marine antimicrobial peptides: nature provides templates for the design of novel compounds against pathogenic bacteria. Int J Mol Sci 17(5):1\u201317","journal-title":"Int J Mol Sci"},{"issue":"7","key":"15_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules22071217","volume":"22","author":"A Falanga","year":"2017","unstructured":"Falanga A, Nigro E, De Biasi MG, Daniele A, Morelli G, Galdiero S, Scudiero O (2017) Cyclic peptides as novel therapeutic microbicides: engineering of human defensin mimetics. Molecules 22(7):1\u201315","journal-title":"Molecules"},{"issue":"2","key":"15_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","volume":"24","author":"Y Fang","year":"2017","unstructured":"Fang Y, Xue JX, Gao S, Lu AQ, Yang DJ, Jiang H, He Y, Shi K (2017) Cleavable PEGylation: a strategy for overcoming the \u201cPEG dilemma\u201d in efficient drug delivery. Drug Deliv 24(2):22\u201332","journal-title":"Drug Deliv"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bcp.2016.09.025","volume":"133","author":"P Fernandes","year":"2017","unstructured":"Fernandes P, Martens E (2017) Antibiotics in late clinical development. Biochem Pharmacol 133:152\u2013163","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"15_CR36","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1002\/jps.21278","volume":"97","author":"CS Fishburn","year":"2008","unstructured":"Fishburn CS (2008) The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics. J Pharm Sci 97(10):4167\u20134183","journal-title":"J Pharm Sci"},{"issue":"12","key":"15_CR37","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/nbt1213-1064a","volume":"31","author":"JL Fox","year":"2013","unstructured":"Fox JL (2013) Antimicrobial peptides stage a comeback(vol 31, pg 379, 2013). Nat Biotechnol 31(12):1066\u20131066","journal-title":"Nat Biotechnol"},{"issue":"1","key":"15_CR38","first-page":"1","volume":"2","author":"A Giuliani","year":"2007","unstructured":"Giuliani A, Pirri G, Nicoletto SF (2007) Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol 2(1):1\u201333","journal-title":"Cent Eur J Biol"},{"issue":"10","key":"15_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/molecules22101743","volume":"22","author":"A Gomes","year":"2017","unstructured":"Gomes A, Teixeira C, Ferraz R, Prudencio C, Gomes P (2017) Wound-healing peptides for treatment of chronic diabetic foot ulcers and other infected skin injuries. Molecules 22(10):2\u201318","journal-title":"Molecules"},{"issue":"5","key":"15_CR40","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1039\/C7SC00770A","volume":"8","author":"Y Gong","year":"2017","unstructured":"Gong Y, Andina D, Nahar S, Leroux JC, Gauthier MA (2017) Releasable and traceless PEGylation of arginine-rich antimicrobial peptides. Chem Sci 8(5):4082\u20134086","journal-title":"Chem Sci"},{"issue":"7","key":"15_CR41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/02713680590968637","volume":"30","author":"YJ Gordon","year":"2005","unstructured":"Gordon YJ, Romanowski EG, McDermott AM (2005) A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res 30(7):505\u2013515","journal-title":"Curr Eye Res"},{"issue":"5","key":"15_CR42","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2174\/1568026616666160713143331","volume":"17","author":"KE Greber","year":"2017","unstructured":"Greber KE, Dawgul M (2017) Antimicrobial peptides under clinical trials. Curr Top Med Chem 17(5):620\u2013628","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"15_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0014-827X(02)01301-0","volume":"58","author":"A Guiotto","year":"2003","unstructured":"Guiotto A, Pozzobon M, Canevari M, Manganelli R, Scarin M, Veronese FM (2003) PEGylation of the antimicrobial peptide nisin a: problems and perspectives. Farmaco 58(1):45\u201350","journal-title":"Farmaco"},{"issue":"5","key":"15_CR45","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1021\/bm500246w","volume":"15","author":"IW Hamley","year":"2014","unstructured":"Hamley IW (2014) PEG-peptide conjugates. Biomacromolecules 15(5):1543\u20131559","journal-title":"Biomacromolecules"},{"issue":"12","key":"15_CR46","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"RE Hancock","year":"2006","unstructured":"Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12):1551\u20131557","journal-title":"Nat Biotechnol"},{"issue":"4","key":"15_CR47","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","volume":"61","author":"A Henninot","year":"2018","unstructured":"Henninot A, Collins JC, Nuss JM (2018) The current state of peptide drug discovery: back to the future? J Med Chem 61(4):1382\u20131414","journal-title":"J Med Chem"},{"key":"15_CR48","unstructured":"Hoffmann R, Berthold N, Nollmann F (2014). Modified antibiotic peptides having variable systemic release. US20140309161 A1. 2014"},{"issue":"5","key":"15_CR49","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.bbamem.2007.01.005","volume":"1768","author":"Y Imura","year":"2007","unstructured":"Imura Y, Nishida M, Ogawa Y, Takakura Y, Matsuzaki K (2007) Action mechanism of tachyplesin I and effects of PEGylation. Biochim Biophys Acta-Biomembr 1768(5):1160\u20131169","journal-title":"Biochim Biophys Acta-Biomembr"},{"issue":"1","key":"15_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4062\/biomolther.2012.20.1.019","volume":"20","author":"SH Joo","year":"2012","unstructured":"Joo SH (2012) Cyclic peptides as therapeutic agents and biochemical tools. Biomol Ther 20(1):19\u201326","journal-title":"Biomol Ther"},{"issue":"6","key":"15_CR51","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/13543776.2016.1176149","volume":"26","author":"P Kosikowska","year":"2016","unstructured":"Kosikowska P, Lesner A (2016) Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003-2015). Expert Opin Ther Pat 26(6):689\u2013702","journal-title":"Expert Opin Ther Pat"},{"issue":"5","key":"15_CR52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1039\/b001942i","volume":"1","author":"JN Lambert","year":"2001","unstructured":"Lambert JN, Mitchell JP, Roberts KD (2001) The synthesis of cyclic peptides. J Chem Soc-Perkin Trans 1(5):471\u2013484","journal-title":"J Chem Soc-Perkin Trans"},{"issue":"10","key":"15_CR53","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","volume":"26","author":"JL Lau","year":"2018","unstructured":"Lau JL, Dunn MK (2018) Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem 26(10):2700\u20132707","journal-title":"Bioorg Med Chem"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ejmech.2015.01.032","volume":"92","author":"DS Lele","year":"2015","unstructured":"Lele DS, Talat S, Kumari S, Srivastava N, Kaur KJ (2015) Understanding the importance of glycosylated threonine and stereospecific action of Drosocin, a proline rich antimicrobial peptide. Eur J Med Chem 92:637\u2013647","journal-title":"Eur J Med Chem"},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","volume":"106","author":"P Lundquist","year":"2016","unstructured":"Lundquist P, Artursson P (2016) Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues. Adv Drug Deliv Rev 106:256\u2013276","journal-title":"Adv Drug Deliv Rev"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2016.00194","volume":"6","author":"M Mahlapuu","year":"2016","unstructured":"Mahlapuu M, Hakansson J, Ringstad L, Bjorn C (2016) Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol 6:1\u201312","journal-title":"Front Cell Infect Microbiol"},{"issue":"16","key":"15_CR57","doi-asserted-by":"publisher","first-page":"8736","DOI":"10.1021\/acs.chemrev.5b00056","volume":"115","author":"V Marti-Centelles","year":"2015","unstructured":"Marti-Centelles V, Pandey MD, Burguete MI, Luis SV (2015) Macrocyclization reactions: the importance of conformational, configurational, and template-induced preorganization. Chem Rev 115(16):8736\u20138834","journal-title":"Chem Rev"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ddtec.2014.02.001","volume":"11","author":"JL Martinez","year":"2014","unstructured":"Martinez JL (2014) General principles of antibiotic resistance in bacteria. Drug Discov Today Technol 11:33\u201339","journal-title":"Drug Discov Today Technol"},{"issue":"11","key":"15_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1021\/cen-v083n011.p017","volume":"83","author":"V Marx","year":"2005","unstructured":"Marx V (2005) Watching peptide drugs grow up. Chem Eng News 83(11):17\u201384","journal-title":"Chem Eng News"},{"issue":"5","key":"15_CR60","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.bbamem.2007.02.005","volume":"1768","author":"MN Melo","year":"2007","unstructured":"Melo MN, Castanho MARB (2007) Omiganan interaction with bacterial membranes and cell wall models. Assigning a biological role to saturation. Biochim Biophys Acta-Biomembr 1768(5):1277\u20131290","journal-title":"Biochim Biophys Acta-Biomembr"},{"issue":"8","key":"15_CR61","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1073\/pnas.92.8.3449","volume":"92","author":"RB Merrifield","year":"1995","unstructured":"Merrifield RB, Juvvadi P, Andreu D, Ubach J, Boman A, Boman HG (1995) Retro and retroenantio analogs of cecropin-melittin hybrids. Proc Natl Acad Sci U S A 92(8):3449\u20133453","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"15_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s10930-018-9755-0","volume":"37","author":"D Migon","year":"2018","unstructured":"Migon D, Neubauer D, Kamysz W (2018) Hydrocarbon stapled antimicrobial peptides. Protein J 37(1):2\u201312","journal-title":"Protein J"},{"issue":"9","key":"15_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules22091430","volume":"22","author":"N Molchanova","year":"2017","unstructured":"Molchanova N, Hansen PR, Franzyk H (2017) Advances in development of antimicrobial peptidomimetics as potential drugs. Molecules 22(9):1\u201360","journal-title":"Molecules"},{"issue":"10","key":"15_CR64","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1016\/j.bmc.2017.09.040","volume":"26","author":"SAHA Monaim","year":"2018","unstructured":"Monaim SAHA, Jad YE, El-Faham A, de la Torre BG, Albericio F (2018) Teixobactin as a scaffold for unlimited new antimicrobial peptides: SAR study. Bioorg Med Chem 26(10):2788\u20132796","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"15_CR65","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1039\/C5SC04392A","volume":"7","author":"SV Moradi","year":"2016","unstructured":"Moradi SV, Hussein WM, Varamini P, Simerska P, Toth I (2016) Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides. Chem Sci 7(4):2492\u20132500","journal-title":"Chem Sci"},{"issue":"6","key":"15_CR66","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1128\/AAC.06335-11","volume":"56","author":"CJ Morris","year":"2012","unstructured":"Morris CJ, Beck K, Fox MA, Ulaeto D, Clark GC, Gumbleton M (2012) Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery. Antimicrob Agents Chemother 56(6):3298\u20133308","journal-title":"Antimicrob Agents Chemother"},{"issue":"7061","key":"15_CR67","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nature04051","volume":"437","author":"PH Mygind","year":"2005","unstructured":"Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sonksen CP, Ludvigsen S, Raventos D, Buskov S, Christensen B, De Maria L, Taboureau O, Yaver D, Elvig-Jorgensen SG, Sorensen MV, Christensen BE, Kjaerulff S, Frimodt-Moller N, Lehrer RI, Zasloff M, Kristensen HH (2005) Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437(7061):975\u2013980","journal-title":"Nature"},{"issue":"8","key":"15_CR68","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1021\/mp500203e","volume":"11","author":"D Oh","year":"2014","unstructured":"Oh D, Shirazi AN, Northup K, Sullivan B, Tiwari RK, Bisoffi M, Parang K (2014) Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization. Mol Pharm 11(8):2845\u20132854","journal-title":"Mol Pharm"},{"key":"15_CR69","first-page":"1","volume":"2","author":"L Otvos","year":"2014","unstructured":"Otvos L, Wade JD (2014) Current challenges in peptide-based drug discovery. Front Chem 2:1\u20134","journal-title":"Front Chem"},{"key":"15_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2018.00281","volume":"9","author":"A Pfalzgraff","year":"2018","unstructured":"Pfalzgraff A, Brandenburg K, Weindl G (2018) Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Front Pharmacol 9:1\u201323","journal-title":"Front Pharmacol"},{"issue":"2","key":"15_CR71","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.drudis.2016.11.003","volume":"22","author":"N Qvit","year":"2017","unstructured":"Qvit N, Rubin SJS, Urban TJ, Mochly-Rosen D, Gross ER (2017) Peptidomimetic therapeutics: scientific approaches and opportunities. Drug Discov Today 22(2):454\u2013462","journal-title":"Drug Discov Today"},{"issue":"10","key":"15_CR72","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1016\/j.bmc.2017.08.031","volume":"26","author":"AFB Rader","year":"2018","unstructured":"Rader AFB, Reichart F, Weinmuller M, Kessler H (2018) Improving oral bioavailability of cyclic peptides by N-methylation. Bioorg Med Chem 26(10):2766\u20132773","journal-title":"Bioorg Med Chem"},{"key":"15_CR73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.actbio.2016.01.035","volume":"33","author":"A Rai","year":"2016","unstructured":"Rai A, Pinto S, Evangelista MB, Gil H, Kallip S, Ferreira MGS, Ferreira L (2016a) High-density antimicrobial peptide coating with broad activity and low cytotoxicity against human cells. Acta Biomater 33:64\u201377","journal-title":"Acta Biomater"},{"key":"15_CR74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biomaterials.2016.01.051","volume":"85","author":"A Rai","year":"2016","unstructured":"Rai A, Pinto S, Velho TR, Ferreira AF, Moita C, Trivedi U, Evangelista M, Comune M, Rumbaugh KP, Simoes PN, Moita L, Ferreira L (2016b) One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model. Biomaterials 85:99\u2013110","journal-title":"Biomaterials"},{"issue":"11","key":"15_CR75","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1021\/acs.bioconjchem.7b00368","volume":"28","author":"U Rajchakit","year":"2017","unstructured":"Rajchakit U, Sarojini V (2017) Recent developments in antimicrobial-peptide-conjugated gold nanoparticles. Bioconjug Chem 28(11):2673\u20132686","journal-title":"Bioconjug Chem"},{"issue":"5","key":"15_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms17050701","volume":"17","author":"A Reinhardt","year":"2016","unstructured":"Reinhardt A, Neundorf I (2016) Design and application of antimicrobial peptide conjugates. Int J Mol Sci 17(5):1\u201321","journal-title":"Int J Mol Sci"},{"issue":"4","key":"15_CR77","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","volume":"54","author":"MJ Roberts","year":"2002","unstructured":"Roberts MJ, Bentley MD, Harris JM (2002) Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54(4):459\u2013476","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"15_CR78","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1128\/AAC.48.8.3112-3118.2004","volume":"48","author":"HS Sader","year":"2004","unstructured":"Sader HS, Fedler KA, Rennie RP, Stevens S, Jones RN (2004) Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity. Antimicrob Agents Chemother 48(8):3112\u20133118","journal-title":"Antimicrob Agents Chemother"},{"issue":"2475067","key":"15_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2475067","volume":"2016","author":"S Santajit","year":"2016","unstructured":"Santajit S, Indrawattana N (2016) Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int 2016(2475067):1\u20138","journal-title":"Biomed Res Int"},{"issue":"32","key":"15_CR80","doi-asserted-by":"publisher","first-page":"13312","DOI":"10.1074\/jbc.M117.794248","volume":"292","author":"EGW Schmidt","year":"2017","unstructured":"Schmidt EGW, Hvam ML, Antunes F, Cameron J, Viuff D, Andersen B, Kristensen NN, Howard KA (2017) Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin. J Biol Chem 292(32):13312\u201313322","journal-title":"J Biol Chem"},{"issue":"3","key":"15_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18030542","volume":"18","author":"MA Scorciapino","year":"2017","unstructured":"Scorciapino MA, Serra I, Manzo G, Rinaldi AC (2017) Antimicrobial dendrimeric peptides: structure, activity and new therapeutic applications. Int J Mol Sci 18(3):1\u201313","journal-title":"Int J Mol Sci"},{"issue":"5","key":"15_CR82","first-page":"4","volume":"96","author":"A Scott","year":"2018","unstructured":"Scott A (2018) Peptide makers face threat from biotechnology how a 1-year-old German start-up could be about to shake up a $1 billion market. Chem Eng News 96(5):4\u20134","journal-title":"Chem Eng News"},{"issue":"6","key":"15_CR83","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/14712598.2017.1315402","volume":"17","author":"JM Sierra","year":"2017","unstructured":"Sierra JM, Fuste E, Rabanal F, Vinuesa T, Vinas M (2017) An overview of antimicrobial peptides and the latest advances in their development. Expert Opin Biol Ther 17(6):663\u2013676","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"15_CR84","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1128\/AAC.02728-13","volume":"58","author":"T Silva","year":"2014","unstructured":"Silva T, Magalhaes B, Maia S, Gomes P, Nazmi K, Bolscher JGM, Rodrigues PN, Bastos M, Gomes MS (2014) Killing of mycobacterium avium by lactoferricin peptides: improved activity of arginine- and D-amino-acid-containing molecules. Antimicrob Agents Chemother 58(6):3461\u20133467","journal-title":"Antimicrob Agents Chemother"},{"key":"15_CR85","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.addr.2015.02.005","volume":"91","author":"JT Sockolosky","year":"2015","unstructured":"Sockolosky JT, Szoka FC (2015) The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy. Adv Drug Deliv Rev 91:109\u2013124","journal-title":"Adv Drug Deliv Rev"},{"issue":"78","key":"15_CR86","doi-asserted-by":"publisher","first-page":"14656","DOI":"10.1039\/C5CC06116D","volume":"51","author":"JM Swiecicki","year":"2015","unstructured":"Swiecicki JM, Di Pisa M, Lippi F, Chwetzoff S, Mansuy C, Trugnan G, Chassaing G, Lavielle S, Burlina F (2015) Unsaturated acyl chains dramatically enhanced cellular uptake by direct translocation of a minimalist oligo-arginine lipopeptide. Chem Commun 51(78):14656\u201314659","journal-title":"Chem Commun"},{"issue":"3","key":"15_CR87","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1046\/j.0014-2956.2001.02728.x","volume":"269","author":"JP Tam","year":"2002","unstructured":"Tam JP, Lu YA, Yang JL (2002) Antimicrobial dendrimeric peptides. Eur J Biochem 269(3):923\u2013932","journal-title":"Eur J Biochem"},{"issue":"5","key":"15_CR88","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/bip.22669","volume":"104","author":"A Tapeinou","year":"2015","unstructured":"Tapeinou A, Matsoukas MT, Simal C, Tselios T (2015) Cyclic peptides on a merry-go-round; towards drug design. Biopolymers 104(5):453\u2013461","journal-title":"Biopolymers"},{"issue":"49","key":"15_CR89","doi-asserted-by":"publisher","first-page":"16198","DOI":"10.1021\/jp106915c","volume":"114","author":"V Teixeira","year":"2010","unstructured":"Teixeira V, Feio MJ, Rivas L, De la Torre BG, Andreu D, Coutinho A, Bastos M (2010) Influence of lysine N-epsilon-trimethylation and lipid composition on the membrane activity of the cecropin A-melittin hybrid peptide CA(1-7)M(2-9). J Phys Chem B 114(49):16198\u201316208","journal-title":"J Phys Chem B"},{"issue":"22","key":"15_CR90","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1021\/cen-v089n022.p021","volume":"89","author":"AM Thayer","year":"2011","unstructured":"Thayer AM (2011) Making peptides at large scale. Chem Eng News 89(22):21\u201325","journal-title":"Chem Eng News"},{"issue":"10","key":"15_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0109939","volume":"9","author":"S Trier","year":"2014","unstructured":"Trier S, Linderoth L, Bjerregaard S, Andresen TL, Rahbek UL (2014) Acylation of glucagon-like peptide-2: interaction with lipid membranes and in vitro intestinal permeability. PLoS One 9(10):1\u201310","journal-title":"PLoS One"},{"issue":"7","key":"15_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0181748","volume":"12","author":"SS Usmani","year":"2017","unstructured":"Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, Ahuja AA, Sharma M, Gautam A, Raghava GPS (2017) THPdb: database of FDA-approved peptide and protein therapeutics. PLoS One 12(7):1\u201312","journal-title":"PLoS One"},{"issue":"5","key":"15_CR93","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0142-9612(00)00193-9","volume":"22","author":"FM Veronese","year":"2001","unstructured":"Veronese FM (2001) Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22(5):405\u2013417","journal-title":"Biomaterials"},{"key":"15_CR94","first-page":"328","volume":"281","author":"L Vidal","year":"2014","unstructured":"Vidal L, Geffard M (2014) Lauryl-poly-L-lysine: a new antimicrobial agent? FEBS J 281:328\u2013328","journal-title":"FEBS J"},{"issue":"15","key":"15_CR95","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1021\/jm4011675","volume":"57","author":"LD Walensky","year":"2014","unstructured":"Walensky LD, Bird GH (2014) Hydrocarbon-stapled peptides: principles, practice, and progress. J Med Chem 57(15):6275\u20136288","journal-title":"J Med Chem"},{"issue":"1","key":"15_CR96","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/ph8010123","volume":"8","author":"G Wang","year":"2015","unstructured":"Wang G, Mishra B, Lau K, Lushnikova T, Golla R, Wang X (2015) Antimicrobial peptides in 2014. Pharmaceuticals (Basel) 8(1):123\u2013150","journal-title":"Pharmaceuticals (Basel)"},{"key":"15_CR97","unstructured":"WebPage, P (n.d.) http:\/\/www.polyphor.com\/pol7080\/. Accessed Jul 2018."},{"issue":"7","key":"15_CR98","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nchem.1062","volume":"3","author":"CJ White","year":"2011","unstructured":"White CJ, Yudin AK (2011) Contemporary strategies for peptide macrocyclization. Nat Chem 3(7):509\u2013524","journal-title":"Nat Chem"},{"key":"15_CR99","unstructured":"WHO (2018) http:\/\/www.who.int\/antimicrobial-resistance\/global-action-plan\/en\/."},{"key":"15_CR100","unstructured":"Willcox MDP, Kumar N, Cole N, et al. (2013) Antimicrobial peptides and uses thereof. WO2013076666 A1. 2013"},{"key":"15_CR101","unstructured":"WIPO (2018) https:\/\/patentscope.wipo.int\/search\/pt\/search.jsf."},{"issue":"10","key":"15_CR102","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1021\/ar800216e","volume":"41","author":"YD Wu","year":"2008","unstructured":"Wu YD, Gellman S (2008) Peptidomimetics. Acc Chem Res 41(10):1231\u20131232","journal-title":"Acc Chem Res"},{"issue":"37","key":"15_CR103","doi-asserted-by":"publisher","first-page":"13872","DOI":"10.1073\/pnas.0601455103","volume":"103","author":"J Yang","year":"2006","unstructured":"Yang J, Chen H, Vlahov IR, Cheng JX, Low PS (2006) Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging. Proc Natl Acad Sci U S A 103(37):13872\u201313877","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6870","key":"15_CR104","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415(6870):389\u2013395","journal-title":"Nature"},{"issue":"5","key":"15_CR105","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1039\/C7BM00006E","volume":"5","author":"JY Zong","year":"2017","unstructured":"Zong JY, Cobb SL, Cameron NR (2017) Peptide-functionalized gold nanoparticles: versatile biomaterials for diagnostic and therapeutic applications. Biomater Sci 5(5):872\u2013886","journal-title":"Biomater Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Antimicrobial Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-3588-4_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:06:36Z","timestamp":1649894796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-13-3588-4_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811335877","9789811335884"],"references-count":104,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-3588-4_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"13 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}